首页> 外文期刊>Journal of Medicinal Chemistry >SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors
【24h】

SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

机译:噻二唑烷酮衍生物的SAR和3D-QSAR研究:糖原合酶激酶3抑制剂的结构要求的探索

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The 2,4-disubstituted thiadiazolidinones(TDZD)are described as the first ATP-noncompetitive GSK-3 inhibitors.Following an SAR study about TDZD,different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biological study are here reported here.Various compounds such as hydantoins,dithiazolidindiones,rhodanines,maleimides,and triazoles were synthesized and screened as GSK-3 inhibitors.After an extensive SAR study among these different heterocyclic families,TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3.A CoMFA analysis was also performed highlighting the molecular electrostatic field interaction in the interaction of TDZDs with GSK-3.Moreover,first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs.
机译:2,4-二取代的噻二唑烷酮(TDZD)被认为是第一个ATP非竞争性GSK-3抑制剂。在SAR研究TDZD之后,杂环中不同的结构修饰旨在测试每个杂原子对生物学研究的影响。合成了各种化合物,如乙内酰脲,二硫唑烷二酮,若丹宁,马来酰亚胺和三唑,并将其筛选为GSK​​-3抑制剂。在这些不同杂环家族中进行了广泛的SAR研究之后,TDZDs被揭示为选择性选择性的特有支架。抑制GSK-3的作用。还进行了CoMFA分析,以突出TDZD与GSK-3相互作用中的分子静电场相互作用。此外,第一个作图研究表明两种结合模式可能暗示了机制上的相关差异,这可能是因为TDZDs的抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号